Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial‐to‐mesenchymal transition via miR‐424‐5p

Diabetic kidney disease (DKD) is well‐acknowledged as one of the most common complications in diabetes mellitus. Recent studies have demonstrated the promising role of mesenchymal stem cell‐derived exosomes (MSC‐exos) as a cell‐free treatment strategy for DKD. The present study sought to investigate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The FASEB journal 2022-10, Vol.36 (10), p.e22517-n/a
Hauptverfasser:	Cui, Chen, Zang, Nan, Song, Jia, Guo, Xinghong, He, Qin, Hu, Huiqing, Yang, Mengmeng, Wang, Yuanqi, Yang, Jingwen, Zou, Ying, Gao, Jing, Wang, Lingshu, Wang, Chuan, Liu, Fuqiang, He, Falian, Hou, Xinguo, Chen, Li
Format:	Artikel
Sprache:	eng
Schlagworte:	diabetic kidney disease exosomes mesenchymal stem cells miR‐424‐5p YAP1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!